Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta
Caring for Children with Cancer and Blood Disorders
The Aflac Cancer Center is committed to providing our pediatric patients a brighter future through advanced medical treatment, family-centered care, a child-friendly environment and innovative research.
Directed by pediatric hematologists/oncologists, our multidisciplinary team offers children and families the emotional, physical and spiritual support they need.
Recognized as one of the top childhood cancer centers in the country by U.S.News & World Report, the Aflac Cancer Center treats more than 350 new cancer patients each year and follows more than 2,500 patients with sickle cell disease, hemophilia and other blood disorders. Our courageous patients range from infants to young adults.
Committed to Pediatric Research
Children’s, in conjunction with Emory University School of Medicine and the Emory Winship Cancer Institute, is committed to excellence and innovation in pediatric cancer and blood disorders research. Our participation in hundreds of national therapeutic and nontherapeutic clinical trials gives our patients access to the latest in treatment for childhood cancer and blood disorders.
Find a Clinical Trial
Visit our new clinical trials database.
This tool allows you to easily search and view our open clinical trials. You will find a brief summary of each trial, objectives and eligibility criteria. |
 |
Highlights:
- Our physicians are widely regarded in national clinical trials and collaborative studies of the Children’s Oncology Group (COG), the National Cancer Institute, the National Institutes of Health and the Pediatric Blood and Marrow Transplant Consortium—among others.
- Children’s ranks as one of the leading childhood cancer and blood disorders centers in the country for enrolling children in clinical trials.
- The Aflac Cancer Center is especially proud of our impact on the cure and overall survival rates of the patients we treat.
At Children’s, we not only stand on medicine's leading edge, we also work to advance it.